Position in INCY
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$16,168,871
-$2,652,639 QoQ
Shares Held
171,790
-9.8% QoQ
Ownership
0.086%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 92.82903545025903.ToString("F0")%
Shared 0.ToString("F0")%
None 7.170964549740963.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF MONTREAL /CAN/ holds $580,215,891 across 80 Biotechnology names. INCY ranks #8 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
390,476 | $174,363,150 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,055,597 | $68,223,231 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
85,524 | $66,079,260 | |
| 4 | ARGX |
Argenx SE
|
85,333 | $62,314,421 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
239,265 | $45,233,045 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
86,183 | $17,206,434 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
515,328 | $17,119,195 | |
| 8 | INCY |
Incyte Corp
This page
|
171,790 | $16,168,871 |
All Filings in INCY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $16,168,871 | 171,790 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $18,821,510 | 190,559 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $13,722,510 | 161,803 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $8,230,427 | 120,858 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $8,298,679 | 137,055 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $11,587,457 | 167,764 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $12,872,047 | 194,736 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $13,208,247 | 217,886 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $37,189,216 | 652,786 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $28,067,818 | 447,011 | Shares | Defined | 2024-02-08 | |
| 2023-09-30 | $23,816,373 | 412,262 | Shares | Defined | 2023-11-01 | |
| 2023-06-30 | $24,327,174 | 390,798 | Shares | Defined | 2023-08-02 | |
| 2023-03-31 | $43,497,937 | 601,881 | Shares | Defined | 2024-06-13 | |
| 2022-12-31 | $17,518,673 | 218,111 | Shares | Defined | 2023-02-01 | |
| 2022-09-30 | $30,863,915 | 463,144 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $38,799,244 | 510,718 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $13,358,521 | 168,201 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $22,633,769 | 308,362 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $35,035,017 | 509,378 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $28,202,981 | 335,231 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $22,565,262 | 277,658 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $31,240,691 | 359,171 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $24,093,034 | 268,476 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $32,535,328 | 312,930 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $15,905,260 | 217,196 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||